D Larregain-Fournier
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Chemotherapy-related skin toxicity 2
-
- Urticaria and Related Conditions 1
- Rheumatoid Arthritis Research and Therapies 1
- Journals
- International Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Obstetrics and Gynecology (1 paper)La Presse Médicale (2 papers)PubMed (3 papers)
- Partner nations
- FranceFrench Guiana
In The Last Decade
D Larregain-Fournier
8 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Hepatology 319
- Oncology 929
- Pathology and Forensic Medicine 186
- Pulmonary and Respiratory Medicine 257
- Reproductive Medicine 57
Countries citing papers authored by D Larregain-Fournier
This map shows the geographic impact of D Larregain-Fournier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Larregain-Fournier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Larregain-Fournier more than expected).
Fields of papers citing papers by D Larregain-Fournier
This network shows the impact of papers produced by D Larregain-Fournier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Larregain-Fournier. The network helps show where D Larregain-Fournier may publish in the future.
Co-authors
The 25 scholars most cited alongside D Larregain-Fournier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 35 | |
| 2 | Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2000 | 1102 |
| 3 | 1995 | 27 | |
| 4 | Maladie de Horton et pseudo-polyarthrite rhizomélique associées à une leucémie lymphoide chronique. | 1984 | 1 |
| 5 | Saturation de la glande thyroide secondaire à l'application cutanée prolongée d'antiseptique iodé. | 1984 | 1 |
| 6 | [Horton's disease and rhizomelic pseudopolyarthritis associated with chronic lymphoid leukemia]. | 1984 | 1 |
| 7 | [Saturation of the thyroid gland secondary to prolonged cutaneous application of iodine antiseptic]. | 1984 | 1 |
| 8 | [Amiodarone: a new cause of hypersensitivity pneumopathy?]. | 1984 | 1 |
About D Larregain-Fournier
D Larregain-Fournier is a scholar working on Dermatology, Rheumatology, Obstetrics and Gynecology, Hepatology and Reproductive Medicine, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chemotherapy-related skin toxicity (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Poisoning and overdose treatments (1 paper), Urticaria and Related Conditions (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Animal Disease Management and Epidemiology (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Hepatology (319 citations), Oncology (929 citations), Pathology and Forensic Medicine (186 citations), Pulmonary and Respiratory Medicine (257 citations) and Reproductive Medicine (57 citations). D Larregain-Fournier has collaborated with scholars based in France and French Guiana. Frequent co-authors include R. Faggiuolo, B Perpoint, N Le Bail, R. Adam, Stephen D. Walter, J Llory, J.L. Misset, Rachid Zidani, C. Focan and Françis Lévi. Their work appears in journals such as International Journal of Cancer, Journal of Clinical Oncology, Obstetrics and Gynecology, La Presse Médicale and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.